Genprex GNPX
NASDAQ GNPX
$3.95 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genprex (GNPX) Cash & Current Investments (2016 - 2026)

Genprex (GNPX) posted quarterly Cash & Current Investments of $18.0 million for Q1 2026, up 420.4% year-over-year from $3.5 million in Q1 2025, and up 130.49% quarter-over-quarter from $7.8 million in Q4 2025.

Genprex (GNPX) Cash & Current Investments (2016 - 2026) Analysis & Trends

Genprex's Cash & Current Investments history runs 11 years deep, the most recent figure standing at $18.0 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 420.4% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at $18.0 million (up 420.4% YoY), while the FY2025 annual figure was $7.8 million, up 388.92% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $18.0 million, up from $7.8 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $34.6 million in Q1 2022, with the low at $1.1 million in Q3 2025.
  • The 5-year median for Cash & Current Investments is $8.2 million (2024), against an average of $11.9 million.
  • The sharpest annual moves came in 2024 and 2026: Cash & Current Investments tumbled 87.29% in 2024, then soared 420.4% in 2026.
  • Genprex's Cash & Current Investments stood at $21.0 million in 2022, then tumbled by 67.85% to $6.7 million in 2023, then plunged by 76.23% to $1.6 million in 2024, then soared by 388.92% to $7.8 million in 2025, then soared by 130.49% to $18.0 million in 2026.
  • Business Quant data shows GNPX's Cash & Current Investments at $18.0 million in Q1 2026, $7.8 million in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Genprex 1.88 Mn -13.28 Mn - 15.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.05 Mn
Dec 31, 2025 7.83 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 3.47 Mn
Dec 31, 2024 1.60 Mn
Sep 30, 2024 1.49 Mn
Jun 30, 2024 2.46 Mn
Mar 31, 2024 8.22 Mn
Dec 31, 2023 6.74 Mn
Sep 30, 2023 11.71 Mn
Jun 30, 2023 9.96 Mn
Mar 31, 2023 18.08 Mn
Dec 31, 2022 20.95 Mn
Sep 30, 2022 25.52 Mn
Jun 30, 2022 30.05 Mn
Mar 31, 2022 34.56 Mn
Sep 30, 2021 42.02 Mn
Jun 30, 2021 44.24 Mn
Mar 31, 2021 47.07 Mn